LCN2 and glioma: MMP-9/NGAL activity was detected in 85.7% of glioma patients and was positively correlated with the activity of MMP-9 and MMP-9 Dimer in Preop-1d urine (Spearman's r = 0.83, r = 0.74, resp.; p < 0.05).